Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah J Tabrizi

Showing results (1-10 of 330) with videos related to

Pageof 33
Sort By:
Handbook of Clinical Neurology|January 13, 2018
Huntington diseaseRhia Ghosh, Sarah J Tabrizi
Biochimica Et Biophysica Acta|July 23, 2008
Prions and the proteasomePelagia Deriziotis, Sarah J Tabrizi
Prion|March 29, 2012
Misfolded PrP and a novel mechanism of proteasome inhibitionRalph Andre, Sarah J Tabrizi
Journal of Molecular Medicine (Berlin, Germany)|April 3, 2013
Peripheral inflammation in neurodegenerationUlrike Träger, Sarah J Tabrizi
Nature Reviews. Neurology|May 26, 2026
Targeting toxic HTT1a could be the key to treating Huntington diseaseFreja Sadler, Sarah J Tabrizi
Movement Disorders : Official Journal of the Movement Disorder Society|June 20, 2003
Models of Parkinson's diseaseMichael Orth, Sarah J Tabrizi
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 26, 2023
Can MSH3 lowering stop HTT repeat expansion in its CAG tract?Ross Ferguson, Sarah J Tabrizi
Advances in Experimental Medicine and Biology|February 11, 2018
Clinical Features of Huntington's DiseaseRhia Ghosh, Sarah J Tabrizi
Current Topics in Behavioral Neurosciences|August 27, 2013
Clinical Aspects of Huntington's DiseaseRhia Ghosh, Sarah J Tabrizi
Antioxidants & Redox Signaling|January 21, 2014
The ubiquitin-proteasome system in neurodegenerationChris McKinnon, Sarah J Tabrizi
Pageof 33

Showing results (1-10 of 330) with videos related to

Sort By:
Pageof 33
Handbook of Clinical Neurology|January 13, 2018
Huntington diseaseRhia Ghosh, Sarah J Tabrizi
Biochimica Et Biophysica Acta|July 23, 2008
Prions and the proteasomePelagia Deriziotis, Sarah J Tabrizi
Prion|March 29, 2012
Misfolded PrP and a novel mechanism of proteasome inhibitionRalph Andre, Sarah J Tabrizi
Journal of Molecular Medicine (Berlin, Germany)|April 3, 2013
Peripheral inflammation in neurodegenerationUlrike Träger, Sarah J Tabrizi
Nature Reviews. Neurology|May 26, 2026
Targeting toxic HTT1a could be the key to treating Huntington diseaseFreja Sadler, Sarah J Tabrizi
Movement Disorders : Official Journal of the Movement Disorder Society|June 20, 2003
Models of Parkinson's diseaseMichael Orth, Sarah J Tabrizi
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 26, 2023
Can MSH3 lowering stop HTT repeat expansion in its CAG tract?Ross Ferguson, Sarah J Tabrizi
Advances in Experimental Medicine and Biology|February 11, 2018
Clinical Features of Huntington's DiseaseRhia Ghosh, Sarah J Tabrizi
Current Topics in Behavioral Neurosciences|August 27, 2013
Clinical Aspects of Huntington's DiseaseRhia Ghosh, Sarah J Tabrizi
Antioxidants & Redox Signaling|January 21, 2014
The ubiquitin-proteasome system in neurodegenerationChris McKinnon, Sarah J Tabrizi
Pageof 33